SSgA SPDR S&P U.S. Health Care Select Sector UCITS ETF (AMS:SXLV)
Netherlands · Delayed Price · Currency is EUR | Assets | 476.94M |
| Expense Ratio | 0.15% |
| PE Ratio | 22.91 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | -5.16% |
| Volume | n/a |
| Open | 40.60 |
| Previous Close | 40.75 |
| Day's Range | 40.60 - 40.65 |
| 52-Week Low | 33.78 |
| 52-Week High | 43.72 |
| Beta | n/a |
| Holdings | 60 |
| Inception Date | Jul 7, 2015 |
About SXLV
SSgA SPDR S&P U.S. Health Care Select Sector UCITS ETF is an exchange traded fund launched and managed by State Street Global Advisors Limited. It is co-managed by State Street Global Advisors, Inc. The fund invests in the public equity markets of the United States. It seeks to invest in the stocks of companies operating in the health care sector. The fund invests in the stocks of large-cap companies. It seeks to replicate the performance of the S&P Health Care Select Sector Index, by investing in the stocks of companies as per their weightings in the index. SSgA SPDR S&P U.S. Health Care Select Sector UCITS ETF was formed on July 7, 2015 and is domiciled in Ireland.
Performance
SXLV had a total return of -5.16% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.59%.
Top 10 Holdings
58.01% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 14.72% |
| Johnson & Johnson | JNJ | 9.79% |
| AbbVie Inc. | ABBV | 7.05% |
| Merck & Co., Inc. | MRK | 4.89% |
| UnitedHealth Group Incorporated | UNH | 4.65% |
| Thermo Fisher Scientific Inc. | TMO | 3.88% |
| Abbott Laboratories | ABT | 3.40% |
| Amgen Inc. | AMGN | 3.29% |
| Intuitive Surgical, Inc. | ISRG | 3.19% |
| Gilead Sciences, Inc. | GILD | 3.15% |